Trademark Search in Canada

TALCEPTRX

View On IC.GC.CA

REGISTERED

on 17 Jun 2019

Last Applicant/ Owned by

ONCXERNA THERAPEUTICS INC.

300, Fifth Avenue, Suite 6040Waltham, Massachusetts 02451

Serial Number

1773545 filed on 22^nd Mar 2016

Registration Number

TMA1027051 registered on 17^th Jun 2019

Registration expiry Date

17^th Jun 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

TALCEPTRX

Trademark usage description

pharmaceutical preparations, namely, antibodies for the treatment and diagnosis of cancer and diseases, disorders and infections in which phosphatidyl Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, antibodies for the treatment and diagnosis of cancer and diseases, disorders and infections in which phosphatidylserine (PS) is a marker, namely, immunosuppressive diseases, ocular neovascular diseases and blood vessel diseases, and viral or parasitic infections of the respiratory tract, lung, alimentary canal, gastrointestinal tract, urogenital tract, kidney, liver, eyes, skin, mucous membranes, lymph nodes, cardiovascular system, blood, blood vessels, muscle, liver, spleen and brain

Classification kind code

Mark Details

Serial Number

1773545

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 15^th Sept 2017	Allowed
Submitted for opposition 51 on 15^th Sept 2017	Allowance Notice Sent
Submitted for opposition 42 on 31^st May 2017	Advertised
Submitted for opposition 26 on 11^th May 2017	Approved
Submitted for opposition 27 on 21^st Mar 2017	Approval Notice Sent
Submitted for opposition 22 on 25^th Aug 2016	Search Recorded
Submitted for opposition 20 on 25^th Aug 2016	Examiner's First Report
Submitted for opposition 31 on 24^th Mar 2016	Formalized
Submitted for opposition 1 on 23^rd Mar 2016	Created
Submitted for opposition 30 on 22^nd Mar 2016	Filed